Research and advocacy
Our research and advocacy programs are driven by a deep commitment to improving the lives of people with blood cancer.
Our research hub
Our advocacy work
Over the past 50 years, the Leukaemia Foundation has invested more than $62 million in cutting-edge research.
We’ve led the way in developing:
- The first-ever National Strategic Action Plan for Blood Cancer
- 11 blood cancer specific optimal care pathways
- Australia’s first national guideline for adults with acute myeloid leukaemia
Thanks to our incredible fundraising community and generous donors we continue to lead the way in transforming care for people with blood cancer across the country. If you’d like to get involved, click here to find out more.
Leading the way with cutting-edge research
The Leukaemia Foundation proudly supports innovative programs which aim to improve diagnostics, treatment and care for people with cancer. We are committed to supporting the careers of promising scientists and clinicians, giving Australians access to global clinical trials.
We encourage groundbreaking Australian research through:
- PhD scholarships to help innovative medical and science graduates pursue a career in blood cancer research
- Prestigious fellowships to support the next generation of our country’s brightest researchers and clinicians
- Delivering access to international trials through our Trials Enabling Program for patients who have exhausted standard treatment options
- Commissioning the Research Roadmap for Blood Cancer report. This 10-year plan outlines how to accelerate breakthroughs in blood cancer research in Australia
Advocating for a better future
We are passionate about improving blood cancer policies and advocating for better access to new medicines and therapies. Our team works across the healthcare sector and with government. Working together, we can improve outcomes for people with blood cancer across Australia.
The Leukaemia Foundation advocates for change through:
- Policy submissions to parliamentary inquiries and consultations
- Submissions to the Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee
- Increasing public awareness of blood cancer signs and symptoms
- Driving future reforms with initiatives such as the largest-ever survey of blood cancer patients, State of the Nation: Blood Cancers in Australia
- Drawing on the lived experiences of people with blood cancer to inform and guide our decision making for services and support.